peptide sequences Search Results


trifluoroacetic acid tfa  (Chem Impex International)
95
Chem Impex International trifluoroacetic acid tfa
Trifluoroacetic Acid Tfa, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/trifluoroacetic acid tfa/product/Chem Impex International
Average 95 stars, based on 1 article reviews
trifluoroacetic acid tfa - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier
antibody against a synthetic peptide corresponding to the residues 1–11 of amino-terminal sequence of scmas  (Ezaki Glico Co Ltd)
90
Ezaki Glico Co Ltd antibody against a synthetic peptide corresponding to the residues 1–11 of amino-terminal sequence of scmas
Antibody Against A Synthetic Peptide Corresponding To The Residues 1–11 Of Amino Terminal Sequence Of Scmas, supplied by Ezaki Glico Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibody against a synthetic peptide corresponding to the residues 1–11 of amino-terminal sequence of scmas/product/Ezaki Glico Co Ltd
Average 90 stars, based on 1 article reviews
antibody against a synthetic peptide corresponding to the residues 1–11 of amino-terminal sequence of scmas - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
peptide sequence gehnlsqndgteqyvnvqkivshpy  (GenScript corporation)
90
GenScript corporation peptide sequence gehnlsqndgteqyvnvqkivshpy
Peptide Sequence Gehnlsqndgteqyvnvqkivshpy, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peptide sequence gehnlsqndgteqyvnvqkivshpy/product/GenScript corporation
Average 90 stars, based on 1 article reviews
peptide sequence gehnlsqndgteqyvnvqkivshpy - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
rabbit polyclonal antibody specific for the lukh-specific peptide sequence kdkrnvtnkdknsc  (GenScript corporation)
90
GenScript corporation rabbit polyclonal antibody specific for the lukh-specific peptide sequence kdkrnvtnkdknsc
(A) Pore formation. PMNs (1×106) were incubated with 0.1–5.0 nM LukGH or 5.0 nM heat-inactivated (h.i.) LukGH for 30 min, and plasma membrane permeability was evaluated using an EtBr uptake assay. Alternatively, LukGH was incubated with αLukH or IgG isotype control antibody at the indicated concentrations for 15 min prior to combining with PMNs. (B) PMN lysis. PMNs (1×106) were incubated with LukGH, h.i. LukGH, and/or antibody as described in panel A and lysis was determined by release of LDH as described in Methods. *P < 0.05 for the indicated comparisons using a one-way ANOVA and Tukey’s post-test.
Rabbit Polyclonal Antibody Specific For The Lukh Specific Peptide Sequence Kdkrnvtnkdknsc, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal antibody specific for the lukh-specific peptide sequence kdkrnvtnkdknsc/product/GenScript corporation
Average 90 stars, based on 1 article reviews
rabbit polyclonal antibody specific for the lukh-specific peptide sequence kdkrnvtnkdknsc - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
human n -formyl peptide [fmmyalf, the n-terminal sequence of mitochondrial nadh dehydrogenase subunit 6 (nd6)]  (GenScript corporation)
90
GenScript corporation human n -formyl peptide [fmmyalf, the n-terminal sequence of mitochondrial nadh dehydrogenase subunit 6 (nd6)]
(A) Pore formation. PMNs (1×106) were incubated with 0.1–5.0 nM LukGH or 5.0 nM heat-inactivated (h.i.) LukGH for 30 min, and plasma membrane permeability was evaluated using an EtBr uptake assay. Alternatively, LukGH was incubated with αLukH or IgG isotype control antibody at the indicated concentrations for 15 min prior to combining with PMNs. (B) PMN lysis. PMNs (1×106) were incubated with LukGH, h.i. LukGH, and/or antibody as described in panel A and lysis was determined by release of LDH as described in Methods. *P < 0.05 for the indicated comparisons using a one-way ANOVA and Tukey’s post-test.
Human N Formyl Peptide [Fmmyalf, The N Terminal Sequence Of Mitochondrial Nadh Dehydrogenase Subunit 6 (Nd6)], supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human n -formyl peptide [fmmyalf, the n-terminal sequence of mitochondrial nadh dehydrogenase subunit 6 (nd6)]/product/GenScript corporation
Average 90 stars, based on 1 article reviews
human n -formyl peptide [fmmyalf, the n-terminal sequence of mitochondrial nadh dehydrogenase subunit 6 (nd6)] - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
15mer peptides synthesised with a five-residue overlap covering the human α-synuclein protein sequence  (Innovagen AB)
90
Innovagen AB 15mer peptides synthesised with a five-residue overlap covering the human α-synuclein protein sequence
(A) Pore formation. PMNs (1×106) were incubated with 0.1–5.0 nM LukGH or 5.0 nM heat-inactivated (h.i.) LukGH for 30 min, and plasma membrane permeability was evaluated using an EtBr uptake assay. Alternatively, LukGH was incubated with αLukH or IgG isotype control antibody at the indicated concentrations for 15 min prior to combining with PMNs. (B) PMN lysis. PMNs (1×106) were incubated with LukGH, h.i. LukGH, and/or antibody as described in panel A and lysis was determined by release of LDH as described in Methods. *P < 0.05 for the indicated comparisons using a one-way ANOVA and Tukey’s post-test.
15mer Peptides Synthesised With A Five Residue Overlap Covering The Human α Synuclein Protein Sequence, supplied by Innovagen AB, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/15mer peptides synthesised with a five-residue overlap covering the human α-synuclein protein sequence/product/Innovagen AB
Average 90 stars, based on 1 article reviews
15mer peptides synthesised with a five-residue overlap covering the human α-synuclein protein sequence - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
peptide sequence 28tnrsskgrsligvdgts46  (ImmunoGen Inc)
90
ImmunoGen Inc peptide sequence 28tnrsskgrsligvdgts46
(A) Pore formation. PMNs (1×106) were incubated with 0.1–5.0 nM LukGH or 5.0 nM heat-inactivated (h.i.) LukGH for 30 min, and plasma membrane permeability was evaluated using an EtBr uptake assay. Alternatively, LukGH was incubated with αLukH or IgG isotype control antibody at the indicated concentrations for 15 min prior to combining with PMNs. (B) PMN lysis. PMNs (1×106) were incubated with LukGH, h.i. LukGH, and/or antibody as described in panel A and lysis was determined by release of LDH as described in Methods. *P < 0.05 for the indicated comparisons using a one-way ANOVA and Tukey’s post-test.
Peptide Sequence 28tnrsskgrsligvdgts46, supplied by ImmunoGen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peptide sequence 28tnrsskgrsligvdgts46/product/ImmunoGen Inc
Average 90 stars, based on 1 article reviews
peptide sequence 28tnrsskgrsligvdgts46 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
peptide corresponding to amino acids 385–399 of the adpa sequence (nh2-caghgrpslpgqrsapcooh)  (Neo MPS Inc)
90
Neo MPS Inc peptide corresponding to amino acids 385–399 of the adpa sequence (nh2-caghgrpslpgqrsapcooh)
(A) Pore formation. PMNs (1×106) were incubated with 0.1–5.0 nM LukGH or 5.0 nM heat-inactivated (h.i.) LukGH for 30 min, and plasma membrane permeability was evaluated using an EtBr uptake assay. Alternatively, LukGH was incubated with αLukH or IgG isotype control antibody at the indicated concentrations for 15 min prior to combining with PMNs. (B) PMN lysis. PMNs (1×106) were incubated with LukGH, h.i. LukGH, and/or antibody as described in panel A and lysis was determined by release of LDH as described in Methods. *P < 0.05 for the indicated comparisons using a one-way ANOVA and Tukey’s post-test.
Peptide Corresponding To Amino Acids 385–399 Of The Adpa Sequence (Nh2 Caghgrpslpgqrsapcooh), supplied by Neo MPS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peptide corresponding to amino acids 385–399 of the adpa sequence (nh2-caghgrpslpgqrsapcooh)/product/Neo MPS Inc
Average 90 stars, based on 1 article reviews
peptide corresponding to amino acids 385–399 of the adpa sequence (nh2-caghgrpslpgqrsapcooh) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
n-terminal peptide sequencing  (Inserm Transfert)
90
Inserm Transfert n-terminal peptide sequencing
(A) Pore formation. PMNs (1×106) were incubated with 0.1–5.0 nM LukGH or 5.0 nM heat-inactivated (h.i.) LukGH for 30 min, and plasma membrane permeability was evaluated using an EtBr uptake assay. Alternatively, LukGH was incubated with αLukH or IgG isotype control antibody at the indicated concentrations for 15 min prior to combining with PMNs. (B) PMN lysis. PMNs (1×106) were incubated with LukGH, h.i. LukGH, and/or antibody as described in panel A and lysis was determined by release of LDH as described in Methods. *P < 0.05 for the indicated comparisons using a one-way ANOVA and Tukey’s post-test.
N Terminal Peptide Sequencing, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/n-terminal peptide sequencing/product/Inserm Transfert
Average 90 stars, based on 1 article reviews
n-terminal peptide sequencing - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
bone peptide sequences  (Biomatik)
90
Biomatik bone peptide sequences
(A) Pore formation. PMNs (1×106) were incubated with 0.1–5.0 nM LukGH or 5.0 nM heat-inactivated (h.i.) LukGH for 30 min, and plasma membrane permeability was evaluated using an EtBr uptake assay. Alternatively, LukGH was incubated with αLukH or IgG isotype control antibody at the indicated concentrations for 15 min prior to combining with PMNs. (B) PMN lysis. PMNs (1×106) were incubated with LukGH, h.i. LukGH, and/or antibody as described in panel A and lysis was determined by release of LDH as described in Methods. *P < 0.05 for the indicated comparisons using a one-way ANOVA and Tukey’s post-test.
Bone Peptide Sequences, supplied by Biomatik, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bone peptide sequences/product/Biomatik
Average 90 stars, based on 1 article reviews
bone peptide sequences - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
b peptides  (GenScript corporation)
90
GenScript corporation b peptides
(A) Pore formation. PMNs (1×106) were incubated with 0.1–5.0 nM LukGH or 5.0 nM heat-inactivated (h.i.) LukGH for 30 min, and plasma membrane permeability was evaluated using an EtBr uptake assay. Alternatively, LukGH was incubated with αLukH or IgG isotype control antibody at the indicated concentrations for 15 min prior to combining with PMNs. (B) PMN lysis. PMNs (1×106) were incubated with LukGH, h.i. LukGH, and/or antibody as described in panel A and lysis was determined by release of LDH as described in Methods. *P < 0.05 for the indicated comparisons using a one-way ANOVA and Tukey’s post-test.
B Peptides, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/b peptides/product/GenScript corporation
Average 90 stars, based on 1 article reviews
b peptides - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
peptide sequencing  (Scharlau Group)
90
Scharlau Group peptide sequencing
(A) Pore formation. PMNs (1×106) were incubated with 0.1–5.0 nM LukGH or 5.0 nM heat-inactivated (h.i.) LukGH for 30 min, and plasma membrane permeability was evaluated using an EtBr uptake assay. Alternatively, LukGH was incubated with αLukH or IgG isotype control antibody at the indicated concentrations for 15 min prior to combining with PMNs. (B) PMN lysis. PMNs (1×106) were incubated with LukGH, h.i. LukGH, and/or antibody as described in panel A and lysis was determined by release of LDH as described in Methods. *P < 0.05 for the indicated comparisons using a one-way ANOVA and Tukey’s post-test.
Peptide Sequencing, supplied by Scharlau Group, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peptide sequencing/product/Scharlau Group
Average 90 stars, based on 1 article reviews
peptide sequencing - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


(A) Pore formation. PMNs (1×106) were incubated with 0.1–5.0 nM LukGH or 5.0 nM heat-inactivated (h.i.) LukGH for 30 min, and plasma membrane permeability was evaluated using an EtBr uptake assay. Alternatively, LukGH was incubated with αLukH or IgG isotype control antibody at the indicated concentrations for 15 min prior to combining with PMNs. (B) PMN lysis. PMNs (1×106) were incubated with LukGH, h.i. LukGH, and/or antibody as described in panel A and lysis was determined by release of LDH as described in Methods. *P < 0.05 for the indicated comparisons using a one-way ANOVA and Tukey’s post-test.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Article Title: Staphylococcus aureus LukGH promotes formation of neutrophil extracellular traps

doi: 10.4049/jimmunol.1301821

Figure Lengend Snippet: (A) Pore formation. PMNs (1×106) were incubated with 0.1–5.0 nM LukGH or 5.0 nM heat-inactivated (h.i.) LukGH for 30 min, and plasma membrane permeability was evaluated using an EtBr uptake assay. Alternatively, LukGH was incubated with αLukH or IgG isotype control antibody at the indicated concentrations for 15 min prior to combining with PMNs. (B) PMN lysis. PMNs (1×106) were incubated with LukGH, h.i. LukGH, and/or antibody as described in panel A and lysis was determined by release of LDH as described in Methods. *P < 0.05 for the indicated comparisons using a one-way ANOVA and Tukey’s post-test.

Article Snippet: To verify that PMN membrane permeability and lysis were caused by LukGH, we inhibited cytolysis with rabbit polyclonal antibody specific for the LukH-specific peptide sequence KDKRNVTNKDKNSC (GenScript, Piscataway, NJ).

Techniques: Incubation, Clinical Proteomics, Membrane, Permeability, Control, Lysis